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Introduction
What is the topic?
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Genetic Significance 
in Pathophysiology
Underlying 
Pathophysiology
• Exact	cause	is	unknown	(Hines	&	Marschall,	2018)
• 90%	are	an	isolated	finding
• 10%	inherited	as	autosomal	dominant	
• Chromaffin	cell	tumors	originating	from	neural	crest	cells	from	the	adrenal	medulla	and	extra-adrenal	sites	(Manimaran,	Khan,	Bharathi,	Thulasi,	&	Anuradha,	2016)
• 80-85%	from	adrenal	medulla
• 15-20%	extra-adrenal:	organ	of	Zuckerkandl,	neck,	thorax,	bladder,	and	prostate
• Most	pheochromocytomas	secrete	norepinephrine	and	epinephrine	at	a	85:15	ratio	(Nagelhout	&	Elisha,	2018,	Hines	&	Marschall,	2018)
• 15%	secrete	epinephrine	predominantly
• Can	also	secrete	dopamine,	though	less	common
• Neural	stimulation	does	not	cause	hormone	release	due	to	lack	of	innervation
• “Rule	of	ten”:	Both	adrenal	glands	involved	in	10%	of	adults	with	tumor,	10-15%	extraadrenal,	and	at	least	10%	are	malignant	
• Malignant	spread	typically	through	venous	and	lymphatic	channels	to	liver	(Nagelhout	&	Elisha,	2018)
Pheochromocytoma	and	Paraganglioma	(PPGL)	
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Why	choose	PPGL?
• Possible	malignant	catecholamine	secreting	tumor
• Incidence	in	general	population:	0.005-0.1%
• Incidence	in	adult	hypertensive	population:	0.1-0.2%	(Farrugia	et	al.,	2017)
• Direct	relation	to	my	past	nursing	practice	in	a	surgical-oncology	progressive	care	unit
• Close	monitoring	of	vital	signs	and	assessments	preoperatively	and	postoperatively	
• Potential	to	cause	fatal	complications	if	left	untreated	(Hekimian	et	al.,	2016)
• No	official	guidelines	for	treatment	(Jimenez,	Tatsui,	Jessop,	Thosani,	&	Jimenez,	2017)
• Field	of	genetics	and	pheo’s	undergoing	significant	changes	in	understanding	(Farrugia	et	al.,	2017;	Kantorovich	&	Pacak,	2018)
• Pheochromocytomas	and	paragangliomas	are	the	highest	hereditary-driven	endocrine	condition	(Kantorovich	&	Pacak,	2018)
• 40%	related	to	mutations	in	well	established	15	driver-genes.	Numbers	are	expected	to	grow
• Anatomic	classifications	fall	short	of	providing	sufficient	insight	into	pathogenesis,	clinical	presentation,	and	prognostic	value	with	respect	to	malignant	potential
• Functional,	pathogenesis-based	classification	may	offer	better	understanding	of	actual	tumorigenesis,	expected	biochemical	profiles,	tumor	location,	and	malignant	potential
• Functional	classification	of	current	established	susceptibility	genes:
• Pseudohypoxia	group
• Kinase	signaling	group
• Wnt	signaling	group
• Disease-modifying	gene	group
• Pathogenesis-based	knowledge	help	design	new	therapeutic	approaches	that	target	specific	gene	pathways
• Example:	Hypoxia-inducible	factor	2⍺	antagonist	(HIF-2⍺)	which	promote	HIF	hydroxylation	and	degradation	of	substances	that	promote	tumorigenesis	at	a	specific	pathogenetic	point
• Additional	clinical	presentations	and	genetic	mutations	will	create	opportunities	to	further	understand	the	pathophysiology	of	pheochromocytoma	and	paraganglioma	(Kantorovich	&	Pacak,	2019)
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• Main	signs	and	symptoms	(catecholamine	excess)
• Hypertension
• Palpitations
• Headache
• Perspiration
• Pallor
• Tremors
• Anxiety
• Less	common	signs	and	symptoms	(Farrugia	et	al.,	2017;	Hekimian	et	al.,	2016)
• Fatigue
• Abdominal	pain
• Nausea
• Vomiting
• Myalgia
• Weight	loss
• Constipation
• Flushing
• Fever
• Potential	manifestations	if	untreated	(Hekimian	et	al.,	2016)
• Myocardial	infarction
• Cardiogenic	shock
• Takotsubo-like	cardiomyopathy
• Hypertensive	crisis
• Pulmonary	edema
• Cerebral	vascular	accident
• Dysrhythmias
• Close	monitoring	of	BP,	HR,	pulse	oximetry	
• Signs	can	occur	once	a	month	or	multiple	times	per	day	ranging	minutes	to	hours
• 24-hour	urine	collection	of	metanephrines	and	catecholamines	or	measurement	of	plasma	free	metanephrines
• Telemetry	monitoring	for	abnormalities:
• Elevation	or	depression	of	ST	segment
• Flattening	or	inversion	of	T	wave
• Prolongation	of	QT	interval
• High	or	peaked	P	waves
• Emphasis	on	BP	mgmt.	(Hines	&	Marschall,	2018)
• Alpha	blockade	before	beta	blockade
• Blocking	vasodilatory	β2-receptors	results	in	unopposed	⍺-agonism	
à vasoconstriction	and	hypertensive	crisis
• Preoperative	goals	(Hines	&	Marschall,	2018;	Tsegay,	Anyango,	Van	Sell,	&	Miller-Anderson,	2008)
• Euvolemia
• Normotensive:	Below	160/90	mmHg	for	at	least	24	hours	before	surgery	
• Surgical	resection	is	the	primary	treatment	strategy
• High	risk	for	morbidity	and	mortality	in	the	perioperative	period	(Bai	et	al.,	2018)
• Can	be	as	high	as	50%
• Improvements	in	preoperative	medical	preparation,	anesthesia,	and	surgical	techniques	have	reduced	risk	to	0-2.9%
• Cardiovascular	related	complications	occurred	in	24%	of	patients	who	underwent	removal	in	a	study	by	Bai	et	al.	2018,	which	compared	similarly	to	previous	research.
• Postoperative	hypotension
• Arrhythmia
• Myocardial	infarction
• Peripheral	vasoconstriction	induced	by	catecholamines	preoperatively	leads	to	possible	use	of	vasoactive	agents	(norepinephrine)	and	volume	expansion	with	crystalloid	or	colloid	products
• Prolonged	exposure	of	catecholamines	to	the	myocardium	and	coronary	arteries	could	presumably	lead	to	collagen	deposition	and	fibrosis	in	the	myocardium
• Acute	left	cardiac	dysfunction	due	to	chronically	elevated	epinephrine	was	a	root	cause	of	hypotension	and	circulatory	failure	after	pheochromocytoma	removal
• Possible	independent	risk	factors	for	severe	morbidity	(Bai	et	al.,	2018)
• Female	sex
• Coronary	heart	disease
• BMI	of	22	± 2.9
• Intraoperative	hemodynamic	instability
• Longer	duration	of	surgery:	171.1	± 73	minutes
• 4	of	the	262	patients	that	died	in	this	study	all	had	coronary	heart	disease	and	died	of	circulatory	collapse
Signs & Symptoms Implications for
Nursing Care
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Conclusion
• Pheochromocytoma	and	paraganglioma	are	rare	neuroendocrine	tumors	associated	with	catecholamine	production
• Surgical	resection	is	the	primary	treatment
• Genetic	research	has	provided	additional	information	regarding	pathogenesis	and	targeted	treatment
• The	classic	triad	of	diaphoresis,	palpitations,	and	headache	has	a	reported	sensitivity	of	89%	and	specificity	of	67%	for	pheochromocytoma	specifically.	In	the	presence	of	hypertension,	it	raises	to	91%	and	94%,	respectively
• Rarity	and	variability	of	these	tumors	make	them	difficult	to	manage	and	many	are	discovered	incidentally	during	radiologic	examinations	or	at	autopsy	
• The	key	to	diagnosing	is	to	first	think	of	it!	(Bai	et	al.,	2018;	Farrugia	et	al.,	2017)
